Volume 69, Issue 1, Pages 4-6 (January 2016)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Volume 60, Issue 4, Pages (October 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.
Volume 60, Issue 2, Pages (August 2011)
Renal Cell Carcinoma: Prognostic Factors and Patient Selection
Volume 71, Issue 2, Pages (February 2017)
Volume 61, Issue 5, Pages (May 2012)
Volume 51, Issue 1, Pages (January 2007)
Volume 73, Issue 3, Pages (March 2018)
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
Volume 53, Issue 5, Pages (May 2008)
Volume 54, Issue 4, Pages (October 2008)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Let the Games Begin (with EAU Approval)
Volume 68, Issue 1, Pages (July 2015)
Prostate Cancer Epidemic in Sight?
Giuseppe Di Lorenzo, Riccardo Autorino, Cora N. Sternberg 
Volume 50, Issue 5, Pages (November 2006)
Volume 59, Issue 2, Pages (February 2011)
Volume 63, Issue 1, Pages (January 2013)
Toxicities of Targeted Therapy and Their Management in Kidney Cancer
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 66, Issue 2, Pages (August 2014)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 51, Issue 3, Pages (March 2007)
Volume 71, Issue 1, Pages 1-3 (January 2017)
Volume 52, Issue 5, Pages (November 2007)
Volume 68, Issue 1, Pages 5-7 (July 2015)
Volume 71, Issue 3, Pages (March 2017)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 65, Issue 4, Pages (April 2014)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 68, Issue 1, Pages (July 2015)
Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma  Viktor Grünwald, Xun Lin, Daniel Kalanovic,
Volume 60, Issue 5, Pages (November 2011)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Laurent Boccon-Gibod  European Urology Supplements 
Prostate Cancer Epidemic in Sight?
Volume 61, Issue 6, Pages (June 2012)
Volume 74, Issue 3, Pages (September 2018)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 66, Issue 5, Pages (November 2014)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 47, Issue 1, Pages (January 2005)
Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection
Volume 53, Issue 1, Pages (January 2008)
Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines’ Recommendations?  Vincenzo Ficarra, Antonio Galfano, Stefano Cavalleri 
Volume 50, Issue 5, Pages (November 2006)
Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma  Sergio Bracarda, Alain Ravaud, Marino.
Volume 73, Issue 2, Pages (February 2018)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
Volume 54, Issue 4, Pages (October 2008)
Bernard Escudier  European Urology Supplements 
Sergio Bracarda  European Urology Supplements 
European Urology is “Your” Journal
Epidemiology of Renal Cell Carcinoma
Volume 51, Issue 6, Pages (June 2007)
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Annika Berntsen, Poul F. Geertsen, Inge Marie Svane  European Urology 
Joaquim Bellmunt  European Urology Supplements 
Volume 76, Issue 1, Pages (July 2019)
Jan Roigas  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
Update on the Medical Treatment of Metastatic Renal Cell Carcinoma
Volume 51, Issue 5, Pages (May 2007)
Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma  Guillermo de Velasco, Axel Bex, Laurence Albiges, Thomas Powles, Brian.
Presentation transcript:

Volume 69, Issue 1, Pages 4-6 (January 2016) Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy  Thomas Powles, Michael Staehler, Börje Ljungberg, Karim Bensalah, Steven E. Canfield, Saeed Dabestani, Rachel Giles, Fabian Hofmann, Milan Hora, Markus A. Kuczyk, Thomas Lam, Lorenzo Marconi, Axel S. Merseburger, Alessandro Volpe, Axel Bex  European Urology  Volume 69, Issue 1, Pages 4-6 (January 2016) DOI: 10.1016/j.eururo.2015.10.017 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Recommendations for patients with metastatic renal cell carcinoma who have failed one line or more of vascular endothelial growth factor receptor-targeted therapy. OS=overall survival. European Urology 2016 69, 4-6DOI: (10.1016/j.eururo.2015.10.017) Copyright © 2015 European Association of Urology Terms and Conditions